PG20 Cystic fibrosis: an update of the basic defects and clinical problems in CF children and adults

Postgraduate Course
Chairs: N. Regamey (Bern, Switzerland), P. Tarsia (Milano, Italy)
Aims: The course aims to transmit the latest knowledge about CFTR dysfunction in CF, how this influences the different organs and leads to new treatments modalities. It will also provide the basics of lung treatment, management of gastro-intestinal problems and other organ complications in both children and adults. Since CF has now become a disease of adults as well, special needs to be addressed are end of life issues and transition of adolescents into adult care.
HERMES LINKS
PAEDIATRIC: Cystic fibrosis, Rare diseases, Acute and chronic lung infections, Inhalation therapy, Epidemiology and environmental health.

---

Educational Material

Handout PG20 Open

Reading list PG20 Open

---

CFTR dysfunction and its relationship to phenotype and development of new treatments restoring CFTR function F. Ratjen (Toronto, Canada)
Early CF lung disease- how to detect, to treat and follow up C. Robertson (Victoria, Australia)
CF microbiology, emerging pathogens and more treatment options J.S. Elborn (Belfast, United Kingdom)
Caring for adult CF patients D. Bilton (London, United Kingdom)
Relationship between CF lung structure and aerosol therapy H. Tiddens (Rotterdam, Netherlands)
Nutritional and gastro-intestinal management, diabetes and liver disease E. Kerem (Jerusalem, Israel)
Transition to adult care and problems in early adulthood S. Madge (London, United Kingdom)
Caring for end-stage lung disease and lung transplantation J.S. Elborn (Belfast, United Kingdom)